Author: Dr. Ramez Barsoum, Resident Medical Officer, Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. DermNet New Zealand Editor in Chief: Adjunct Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by: Gus Mitchell. July 2018.
Melanocytes make two forms of melanin in the skin, hair and eyes.
The melanocortin 1 receptor (MC1R) gene encodes the receptor of melanocortin stimulating hormone (MSH), which is found on the surface of melanocytes.
MC1R is coded at 16q24.3; it is mapped on the long arm of chromosome 16, in position 24.3 near the telomere (the protective cap at the end of the chromosome that shortens with every replication) .
The MC1R gene is highly polymorphic in Caucasian populations, with more than 80 variants described in the population [1–5]. While the exact number of people carrying the MC1R gene variants is difficult to determine globally, population based studies have estimated that 1–2% of the population carries a variant allele for this gene. This number is very variable depending on the region and population.
In populations with North European ancestry:
A phenotype refers to the observable features related to the gene, which for the MC1R gene is hair colour.
Hair colour is an autosomal recessive trait expressed by MC1R gene.
Not all MC1R variants are associated with red hair.
People carrying a homozygous (RR) or compound (Rr) heterozygous R allele will often have at least one of the following:
MC1R germline mutations have been shown to increase the risk of cutaneous melanoma. MC1R phenotypic traits make an individual more susceptible to ultraviolet (UV) damage and melanoma may occur without excessive UV exposure. In patients with MC1R gene variants, melanoma occurs more frequently and at an earlier age at onset than in the general population.
Other germline mutations that increase the risk of melanoma include cyclin-dependent kinase inhibitor 2A (CDKN2A), and cyclin-dependent kinase 4 (CDK4) .
The risk of melanoma due to MC1R mutation is moderate compared to CDKN2A and CDK4 mutations. MC1R variants may modify CDKN2A penetrance, increasing the incidence and decreasing the age at onset of melanoma by up to 21 years, when compared to individuals with CDK2NA mutations alone .
Some studies have suggested individuals with at least one MC1R variant allele had a 5–15-fold increase in susceptibility to v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutant melanomas . This finding needs further investigation, as other studies have not found the same association.
A thorough genetic pedigree can indicate whether there is a MC1R gene variant that runs in the family, and its inheritance pattern. Genetic testing can be indicated if there is a strong family history of melanoma in an individual with red hair and other phenotypic traits.
However, genetic testing for MC1R variants is most often undertaken for research purposes. The entire coding region is assessed through a bi-directional Sanger Sequence Analysis.
People carrying the MC1R variant genes should be advised to undertake regular self-skin examination from early adult life, and to take the opportunity for skin checks by a trained health professional. Watch out for pigmented and non-pigmented skin lesions with the following characteristics.
See the DermNet NZ bookstore.
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.